
Gilead Sciences have said Bristol-Myers Squibb exec Johanna Mercier will be the firm’s new Chief Commercial Officer. In her new …

Genmab (NASDAQ: GEN) has announced that the company is set to receive a milestone payment of $30 million from its …
Traditionally, pharma companies have been run as research-based organisations relying on well-integrated internal R&D capabilities to feed their commercial pipelines …
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
FibroFind appoints Professor Andrew Fisher as Chief Medical Officer

